Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an update.
Australian Clinical Labs Ltd announced the cessation of 164,164 ordinary fully paid securities due to an on-market buy-back. This move is part of the company’s capital management strategy, potentially impacting its market positioning by optimizing its capital structure and possibly enhancing shareholder value.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Ltd operates in the healthcare industry, focusing on providing pathology services. The company is known for its comprehensive range of diagnostic services, catering to both public and private healthcare sectors across Australia.
YTD Price Performance: -13.82%
Average Trading Volume: 911,278
Technical Sentiment Signal: Buy
Current Market Cap: A$582.3M
See more data about ACL stock on TipRanks’ Stock Analysis page.